LCM Genect is an Italian company committed to the development of new tests for molecular diagnosis and pharmacogenetics.
Our goal is to provide Precision and Preventive Medicine to all patients earlier, by delivering technological innovation as well as reliable tests, so that their outcomes may be used to personalize therapy protocols, bringing tangible benefits to everyone.
LCM Genect is part of the LCM Group, which specializes in the supply chain of chemicals, especially APIs for the pharmaceutical industry.
The focus of our entire Group is therefore on health and wellbeing.
Liquid biopsy is a primary focus of our R&D department and our top-level scientific team is actively working on high-sensitivity tests for cancer, using molecular biology approaches like NGS and Real-Time.
In our vision, molecular diagnosis and pharmacogenetics can become an opportunity for everyone’s life.
LCM Genect is both ISO 9001 and ISO 13485 certified and the Holding Company, L.C.M. SPA, was the first Italian trading company authorised by the Italian Medicine Agency to import Active Pharmaceutical Ingredients.